Graph AI aims to modernise how drugmakers detect and report adverse drug events, an area heavily dependent on manual, ...
California based Graph AI, focused on patient safety and pharmacovigilance, announced its $3 million Seed round, led by Bessemer Venture Partners. The investment will enable Graph to accelerate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback